Back to top

medical-devices: Archive

Zacks Equity Research

Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up

Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.

BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change INSPNegative Net Change

Zacks Equity Research

Masimo (MASI) Q1 Earnings Beat Estimates, '24 EPS View Up

Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.

BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change MASINegative Net Change

Zacks Equity Research

Fresenius Medical (FMS) Q1 Earnings Beat, Operating Margin Up

Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.

BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change FMSPositive Net Change

Debanjana Dey

4 Stocks to Buy in a Thriving Outpatient Home Health Industry

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.

DVANegative Net Change EHCNegative Net Change PNTGPositive Net Change OPCHNegative Net Change

Santanu Roy

3 Stocks Backed by High Efficiency to Strengthen Your Portfolio

Invest in companies like Option Care Health (OPCH), ReWalk Robotics Ltd. (LFWD) and Garmin (GRMN), as they boast higher efficiency levels.

GRMNNegative Net Change OPCHNegative Net Change LFWDPositive Net Change

Zacks Equity Research

Veracyte (VCYT) Reports Narrower Q1 Loss, Raises '24 Sales View

Veracyte's (VCYT) first-quarter 2024 performance reflects the strength of its testing business.

RMDNegative Net Change VCYTNegative Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Globus Medical (GMED) Q1 Earnings Top Estimates, Margins Fall

Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.

RMDNegative Net Change GMEDPositive Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings

Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.

ALCNegative Net Change PACBNegative Net Change IGMSNegative Net Change ERASNegative Net Change

Zacks Equity Research

Integra's (IART) Q1 Earnings Match Estimates, Margins Down

Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.

BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change IARTNegative Net Change

Zacks Equity Research

Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y

Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.

BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change SWAVNo Net Change

Zacks Equity Research

Henry Schein (HSIC) Tops Q1 Earnings, Lowers '24 Sales View

Henry Schein's (HSIC) first-quarter performance reflects a strong recovery from last year's cyber incident.

RMDNegative Net Change HSICPositive Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

GE HealthCare (GEHC) Unveils Head-Only MR Scanner SIGNA MAGNUS

GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.

BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change GEHCNegative Net Change

Shaun Pruitt

Don't Overlook These Top Medical Stocks as Q1 Earnings Approach

Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.

LGNDPositive Net Change PENNegative Net Change OSCRPositive Net Change

Zacks Equity Research

PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?

PetIQ's (PETQ) first-quarter results are likely to reflect growth in the Product and Services segments of the business.

ALCNegative Net Change BPMCNegative Net Change ADVMNegative Net Change PETQPositive Net Change

Zacks Equity Research

Will These 5 Medical Device Stocks Beat This Earnings Season?

Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.

MCKPositive Net Change FMSPositive Net Change INGNPositive Net Change NVRONegative Net Change INSPNegative Net Change

Riya Anand

Should SNDL (SNDL) be in Your Portfolio Ahead of Q1 Earnings?

SNDL's (SNDL) first-quarter performance is expected to benefit from reduced cost expenses and expansion into the liquor retail segment.

ALCNegative Net Change GRTSNo Net Change SNDLNegative Net Change ERASNegative Net Change

Zacks Equity Research

McKesson (MCK) to Report Q4 Earnings: What's in the Cards?

McKesson's (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.

MCKPositive Net Change ALCNegative Net Change FMSPositive Net Change RDNTNegative Net Change

Zacks Equity Research

Omnicell (OMCL) Q1 Earnings Top Estimates, Revenues Down Y/Y

Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.

OMINegative Net Change OMCLNegative Net Change MEDPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates

Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.

BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change AVNSPositive Net Change

Zacks Equity Research

Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up

Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.

BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change SRDXNegative Net Change

Zacks Equity Research

Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up

Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.

BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change HOLXNegative Net Change

Zacks Equity Research

Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up

Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.

BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change LNTHNegative Net Change

Zacks Equity Research

DaVita (DVA) Q1 Earnings & Revenues Top Estimates, Margins Up

DaVita's (DVA) robust segmental revenues drive its first-quarter performance.

BSXNegative Net Change DVANegative Net Change ALGNNegative Net Change RMDNegative Net Change

Zacks Equity Research

Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline

Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.

BSXNegative Net Change ALGNNegative Net Change RMDNegative Net Change BRKRNegative Net Change

Zacks Equity Research

GE Healthcare's (GEHC) Revolution RT to Aid Cancer Treatment

GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.

BSXNegative Net Change ECLNegative Net Change ALGNNegative Net Change GEHCNegative Net Change